甘化科工：10月23日召开董事会会议

Group 1 - The core point of the article is that GanHua Science and Technology (SZ 000576) held its 14th meeting of the 11th board of directors on October 23, 2025, to review proposals regarding the revision and formulation of certain company systems [1] - For the first half of 2025, the company's revenue composition shows that manufacturing accounted for 99.04%, while other sectors contributed 0.96% [1] - As of the time of reporting, GanHua Science and Technology has a market capitalization of 4.6 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine, while the primary market is facing challenges in fundraising [1]